Cardlytics Inc (CDLX)
Official siteCOMMUNICATION SERVICES • ADVERTISING AGENCIES • NASDAQ
Market Cap: $8.18M
Last updated: Nov 17, 2026 at 11:01 AM ET
Cardlytics Inc (CDLX) Stock Forecast
Analysts expect Cardlytics (CDLX) to earn -$2.69 per share in the fiscal year ending Dec 31, 2026, on revenue of $140.12M. Of 4 analysts, 0 rate the stock Buy or Strong Buy, 3 Hold and 1 Sell or Strong Sell, for a consensus of Sell. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$3.96.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 3.50, inside the Sell band from 3.5 up to 4.5. Sell and Strong Sell make up 25% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 0 | 0.0% |
| Hold | 3 | 75.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 25.0% |
- Consensus
- Sell
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates rise 7.9%.
- Fiscal year ending Dec 31, 2026
- -$2.69
- EPS consensus, revenue $140.12M
- Fiscal year ending Dec 31, 2027
- -$3.96
- EPS consensus, revenue $151.25M
- Next report
- Mar 2, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$2.69 | -$4.05 to -$1.32 | 2 | $140.12M | $139.60M to $141.08M | 3 |
| Dec 31, 2027 | -$3.96 | -$5.26 to -$2.65 | 2 | $151.25M | $141.08M to $161.30M | 4 |
Quarterly Estimates
The EPS consensus falls from -$0.86 for the quarter ending Dec 31, 2026 to -$1.45 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.86 | -$1.14 to -$0.56 | 5 | $36.25M | $34.79M to $37.36M | 5 |
| Mar 31, 2027 | -$1.45 | -$2.02 to -$0.87 | 2 | $32.08M | $29.96M to $34.20M | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$2.31.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$2.69 | -$2.31 | -$2.31 | -$2.31 | -$2.31 | N/A |
| Fiscal year ending Dec 31, 2027 | -$3.96 | -$3.30 | -$3.30 | -$3.30 | -$3.30 | N/A |
| Quarter ending Mar 31, 2027 | -$1.45 | -$1.39 | -$1.39 | -$1.39 | -$1.39 | N/A |
Frequently Asked Questions About CDLX
What is the CDLX stock forecast?
Consensus analyst estimates put Cardlytics's EPS at -$2.69 for the fiscal year ending Dec 31, 2026, on revenue of $140.12M. The consensus rating from 4 analysts is Sell.
How do analysts rate CDLX stock?
Of 4 analysts covering Cardlytics, 0 rate it Strong Buy, 0 Buy, 3 Hold, 0 Sell and 1 Strong Sell, for a consensus of Sell.
What EPS do analysts expect from CDLX next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.69, with estimates from -$4.05 to -$1.32 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$3.96, with estimates from -$5.26 to -$2.65 from 2 analysts.
What revenue do analysts expect from Cardlytics next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $140.12M, with estimates from $139.60M to $141.08M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $151.25M, with estimates from $141.08M to $161.30M.
How many analysts cover CDLX?
4 analysts rate Cardlytics stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
CDLX pages: Overview, Earnings, Forecast, Financials, Competitors